Rapid establishment of a national surveillance of COVID-19 hospitalizations in Belgium
- PMID: 33292566
- PMCID: PMC7673251
- DOI: 10.1186/s13690-020-00505-z
Rapid establishment of a national surveillance of COVID-19 hospitalizations in Belgium
Erratum in
-
Correction to: Rapid establishment of a national surveillance of COVID-19 hospitalizations in Belgium.Arch Public Health. 2021 Aug 18;79(1):147. doi: 10.1186/s13690-021-00661-w. Arch Public Health. 2021. PMID: 34407883 Free PMC article. No abstract available.
Abstract
Background: In response to the COVID-19 epidemic, caused by a novel coronavirus, it was of great importance to rapidly collect as much accurate information as possible in order to characterize the public health threat and support the health authorities in its management. Hospital-based surveillance is paramount to monitor the severity of a disease in the population.
Methods: Two separate surveillance systems, a Surge Capacity survey and a Clinical survey, were set up to collect complementary data on COVID-19 from Belgium's hospitals. The Surge Capacity survey collects aggregated data to monitor the hospital capacity through occupancy rates of beds and medical devices, and to follow a set of key epidemiological indicators over time. Participation is mandatory and the daily data collection includes prevalence and incidence figures on the number of COVID-19 patients in the hospital. The Clinical survey is strongly recommended by health authorities, focusses on specific patient characteristics and relies on individual patient data provided by the hospitals at admission and discharge.
Conclusions: This national double-level hospital surveillance was implemented very rapidly after the first COVID-19 patients were hospitalized and revealed to be crucial to monitor hospital capacity over time and to better understand the disease in terms of risk groups and outcomes. The two approaches are complementary and serve different needs.
Keywords: COVID-19; Hospital capacity; Hospital outcome; Hospital-based surveillance.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures



References
-
- World Health Organization. WHO Director-General’s opening remarks at the media briefing on COVID-19 - 11 March 2020 [Internet]. 2020. Available from: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-re....
-
- World Health Organization. Coronavirus disease (COVID-2019) situation reports. [Internet]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situatio....
-
- Spiteri G, Fielding J, Diercke M, Campese C, Enouf V, Gaymard A, et al. First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020. Eurosurveillance [Internet]. 2020 [cited 2020 Jul 9];25. Available from: https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2020.25.9..... - DOI - PMC - PubMed
-
- Federal Public Service (FPS) Health, Food Chain Safety and Environment. “One repatriated Belgian has tested positive for the novel coronavirus” [Internet]. 2020. Available from: https://www.info-coronavirus.be/en/news/one-repatriated-belgian-has-test....
-
- Sciensano. COVID-19 epidemiological update [Internet]. Available from: https://covid-19.sciensano.be/fr/covid-19-situation-epidemiologique.
LinkOut - more resources
Full Text Sources